StockData
VivoSim Labs, INC. logo

VivoSim Labs, INC. (VIVS) stock

VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$0.12−0.00 (-2.91%)

Close on Nov 17, 2026Market cap $383.64KP/E –Yield –

VivoSim Labs operating margin

Operating margin is operating income as a percentage of revenue.

VivoSim Labs's operating margin for the twelve months ending Jun 30, 2026 was -10117.0%. For fiscal 2026 it was -8768.7%, against -8761.1% the year before. The highest annual figure on record is -195.4% in fiscal 2010.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Mar 31, 2026-8768.7%−7.6
FY2025Mar 31, 2025-8761.1%+5079.3
FY2024Mar 31, 2024-13840.4%−9048.2
FY2023Mar 31, 2023-4792.2%−4026.9
FY2022Mar 31, 2022-765.3%+212.6
FY2020Mar 31, 2020-977.9%−95.5
FY2019Mar 31, 2019-882.4%−116.1
FY2018Mar 31, 2018-766.3%+145.7
FY2017Mar 31, 2017-911.9%+1693.8
FY2016Mar 31, 2016-2605.7%+2700.2
FY2015Mar 31, 2015-5306.0%−4527.4
FY2012Dec 31, 2012-778.5%−540.7
FY2011Dec 31, 2011-237.9%−42.5
FY2010Dec 31, 2010-195.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ2 2026Jun 30, 2026-15327.8%−7449.4
Q4 FY2026CQ1 2026Mar 31, 2026-7967.5%−1783.2
Q3 FY2026CQ4 2025Dec 31, 2025-10576.9%+3873.1
Q2 FY2026CQ3 2025Sep 30, 2025-9410.7%−717.4
Q1 FY2026CQ2 2025Jun 30, 2025-7878.4%+803.7
Q4 FY2025CQ1 2025Mar 31, 2025-6184.3%+4491.5
Q3 FY2025CQ4 2024Dec 31, 2024-14450.0%+59150.0
Q2 FY2025CQ3 2024Sep 30, 2024-8693.3%−3100.0
Q1 FY2025CQ2 2024Jun 30, 2024-8682.1%−3880.2
Q4 FY2024CQ1 2024Mar 31, 2024-10675.9%−8111.7
Q3 FY2024CQ4 2023Dec 31, 2023-73600.0%−69244.2
Q1 FY2024CQ2 2023Jun 30, 2023-5593.3%−5465.8
Q4 FY2023CQ1 2023Mar 31, 2023-4801.9%−3045.5
Q3 FY2023CQ4 2022Dec 31, 2022-2564.1%−2009.1
Q2 FY2023CQ3 2022Sep 30, 2022-4355.8%−3379.6
Q4 FY2022CQ1 2022Mar 31, 2022-127.5%+925.7
Q3 FY2020CQ4 2019Dec 31, 2019-1756.4%−918.6
Q2 FY2020CQ3 2019Sep 30, 2019-555.0%+82.2
Q1 FY2020CQ2 2019Jun 30, 2019-976.2%+123.5
Q4 FY2019CQ1 2019Mar 31, 2019-1053.2%−367.0
Q3 FY2019CQ4 2018Dec 31, 2018-837.7%−151.8
Q2 FY2019CQ3 2018Sep 30, 2018-637.2%+69.7
Q1 FY2019CQ2 2018Jun 30, 2018-1099.7%−69.4
Q4 FY2018CQ1 2018Mar 31, 2018-686.2%+630.0
Q3 FY2018CQ4 2017Dec 31, 2017-685.9%+150.8
Q2 FY2018CQ3 2017Sep 30, 2017-706.9%−18.1
Q1 FY2018CQ2 2017Jun 30, 2017-1030.3%–
Q4 FY2017CQ1 2017Mar 31, 2017-1316.3%–
Q3 FY2017CQ4 2016Dec 31, 2016-836.8%–
Q2 FY2017CQ3 2016Sep 30, 2016-688.9%–

More VivoSim Labs figures

See a number that looks wrong?